[8-K] Avalon GloboCare Corp. Reports Material Event

Rhea-AI Filing Summary

Globant S.A. (NYSE: GLOB) has disclosed via Form 6-K that Chief Operating Officer Patricia Pomies will resign effective 31 Jul 2025. The departure was described as a mutual agreement. The company does not plan to appoint a direct successor; instead, Pomies’ duties will be divided among existing leaders to maintain operational continuity. The filing is incorporated by reference into Globant’s active shelf (F-3) and equity compensation (S-8) registrations.

Positive

• Duties reassigned internally, suggesting a potentially deep leadership bench and continuity plans.

Negative

• Loss of COO without immediate replacement could create operational execution risk and signal possible internal friction.

Insights

Corporate Governance Expert

TL;DR: C-suite exit; no successor named—modest governance risk but limited immediate financial impact.

The resignation of a long-standing COO eliminates a central operational leader, raising questions about execution consistency as Globant scales. However, redistributing responsibilities can minimize disruption if the broader management bench is strong. Because no financial guidance or strategic shift is announced, near-term fundamentals remain unchanged. Investors should monitor future disclosures for clarity on leadership structure and potential talent retention costs.

false 0001630212 0001630212 2025-07-28 2025-07-28 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): July 28, 2025

AVALON GLOBOCARE CORP.

(Exact name of registrant as specified in its charter)

Delaware		001-38728		47-1685128
(State or other jurisdiction of incorporation)		(Commission File Number)		(I.R.S. Employer Identification Number)

4400 Route 9 South, Suite 3100, Freehold, NJ 07728

(Address of principal executive offices)

(732) 780-4400

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.)

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.0001 per share		ALBT		The Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01. Entry into a Material Definitive Agreement.

On July 28, 2025, Avalon GloboCare Corp., a Delaware corporation (the “Company”), entered into a waiver (the “Waiver”) with Mast Hill Fund, L.P. (the “Investor”), with respect to that certain senior secured promissory note originally issued by the Company to Investor on June 5, 2024 (the “Note”). The Waiver provides for an extension of the maturity date of the Note to August 31, 2025. The foregoing description of the terms of the Waiver and the transactions contemplated thereby, does not purport to be complete and is qualified in its entirety by reference to the copy of the Waiver filed hereto as Exhibit 10.1 to this Current Report on Form 8-K, and is incorporated herein by reference.

Item 9.01. Financial Statement and Exhibits.

(d) Exhibits

Exhibit No.		Description
10.1		Waiver by and between the Company and Investor, dated as of July 28, 2025
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	AVALON GLOBOCARE CORP.
Dated: July 29, 2025	By:	/s/ Luisa Ingargiola
	Name:	Luisa Ingargiola
	Title:	Chief Financial Officer

2

FAQ

Why did Globant (GLOB) file a Form 6-K on 29 July 2025?

To report the mutually agreed resignation of COO Patricia Pomies effective 31 Jul 2025.

Is Globant appointing a new COO after Patricia Pomies’ resignation?

No; the company will redistribute her responsibilities among current leaders.

When is the COO resignation effective?

The resignation takes effect on 31 July 2025.

Does the filing affect Globant’s existing registration statements?

Yes, the 6-K is incorporated by reference into Globant’s Form F-3 and multiple Form S-8 registrations.

Are there any financial results or guidance changes in this Form 6-K?

No. The filing strictly addresses the leadership change; no earnings or guidance figures are provided.